|
⚲
|
| Keyboard |
| Data Collective IV LP
✚
|
|
|---|---|
| CIK # | 0001664972 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001664972] | |
| 4 | [0001664972] | |
| D | [0001664972] | |
| SC 13D | [0001664972] | |
| SC 13G | [0001664972] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Data Collective IV LP | OKLO Inc | [2024-05-20] |
| Data Collective IV LP | Recursion Pharmaceuticals Inc | [2022-02-14] |
| Data Collective IV LP | Embark Technology Inc | [2021-11-19] |
| Data Collective IV LP | Evolv Technologies Holdings Inc | [2021-07-26] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Embark Technology Inc EMBK
Class A Common Stock
|
2022-08-30 | Buy | 10,000 | $9.64 | 96,400 |
|
Embark Technology Inc EMBK
Class A Common Stock
|
2022-08-18 | Buy | 10,000 | $11.64 | 116,400 |
|
Embark Technology Inc EMBK
Class A Common Stock
|
2022-08-16 | Buy | 122,000 | $0.84 | 102,480 |
|
Recursion Pharmaceuticals Inc RXRX
Common Stock
|
2021-04-20 | Conversion | 3,951,141 | ||
|
Recursion Pharmaceuticals Inc RXRX
Common Stock
|
2021-04-20 | Other | 3,951,141 | ||
|
Recursion Pharmaceuticals Inc RXRX
Class A Common Stock
|
2021-04-20 | Other | 3,951,141 | ||
|
Recursion Pharmaceuticals Inc RXRX
Common Stock
|
2021-04-20 | Conversion | 3,726,963 | ||
|
Recursion Pharmaceuticals Inc RXRX
Common Stock
|
2021-04-20 | Other | 3,726,963 | ||
|
Recursion Pharmaceuticals Inc RXRX
Class A Common Stock
|
2021-04-20 | Other | 3,726,963 | ||
|
Recursion Pharmaceuticals Inc RXRX
Common Stock
|
2021-04-20 | Conversion | 5,941,120 | ||
|
Recursion Pharmaceuticals Inc RXRX
Series B Preferred Stock · derivative
|
2021-04-20 | Conversion | 1,073,595 | $0.00 | |
|
Recursion Pharmaceuticals Inc RXRX
Series A Preferred Stock · derivative
|
2021-04-20 | Conversion | 3,771,996 | $0.00 | |
|
Recursion Pharmaceuticals Inc RXRX
Series C Preferred Stock · derivative
|
2021-04-20 | Conversion | 730,353 | $0.00 | |
|
Recursion Pharmaceuticals Inc RXRX
Series C Preferred Stock · derivative
|
2021-04-20 | Conversion | 1,095,529 | $0.00 | |
|
Recursion Pharmaceuticals Inc RXRX
Series D Preferred Stock · derivative
|
2021-04-20 | Conversion | 3,726,963 | $0.00 | |
|
Recursion Pharmaceuticals Inc RXRX
Series B Preferred Stock · derivative
|
2021-04-20 | Conversion | 3,220,788 | $0.00 | |
|
Recursion Pharmaceuticals Inc RXRX
Common Stock
|
2021-04-20 | Other | 5,941,120 | ||
|
Recursion Pharmaceuticals Inc RXRX
Class A Common Stock
|
2021-04-20 | Other | 5,941,120 |